Onconova Therapeutics, Inc. (ONTX)

3.83
NASDAQ
Prev Close 3.83
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.30 / 40.00
Exchange NASDAQ
Shares Outstanding 2.74B
Market Cap 10.55M
Div & Yield N.A. (N.A)

Latest News

Onconova Announces Enrollment Of First Patient In Japan By SymBio

Onconova Announces Enrollment Of First Patient In Japan By SymBio

Global Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes Now Active in More than 90 Sites

6 Stocks Under $10 Making Big Moves Higher

6 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Onconova Therapeutics, Inc. Reports Recent Business Highlights And Year-end 2015 Financial Results

Onconova Therapeutics, Inc. Reports Recent Business Highlights And Year-end 2015 Financial Results

Company Outlines Key Objectives for 2016

Onconova Therapeutics, Inc. Receives Notice Of Termination for Convenience From Baxalta

Onconova Therapeutics, Inc. Receives Notice Of Termination for Convenience From Baxalta

Rights to Commercialize Rigosertib in Europe to Revert to Onconova

Onconova Therapeutics Announces Registered Direct Offering

Onconova Therapeutics Announces Registered Direct Offering

Gross Proceeds to Support Phase 3 Development of Rigosertib in MDS

Onconova Enrolls First Patient In Phase 3 INSPIRE Trial Of Rigosertib

Onconova Enrolls First Patient In Phase 3 INSPIRE Trial Of Rigosertib

Patient Randomized at MD Anderson Cancer Center; Four U.S. Sites Activated